Carbapenem-resistant Enterobacteria (CRE) Treatments
Current effective antibiotics for the treatment of infections caused by carbapenem-resistant enterobacteria (CRE) and the likelihood that these antibiotics will still be effective 10 years from now. Treatment options for CRE infections are very limited and resistance to antibiotics currently in use is rising. Polymyxins such as colistin and polymyxin B have been widely used […]


